Compare Cardinal Health Inc (CAH) vs Visa Inc (V) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Visa Inc — how do they compare? Cardinal Health Inc trades at $228.59 (market cap $53.89B), while Visa Inc trades at $354.81 (market cap $677.06B). The key difference: Visa Inc is far larger — about 12.6× Cardinal Health Inc's market cap, and Cardinal Health Inc pays the higher dividend (0.89%). Which is the better fit depends on your goals.
| CAH | V | |
|---|---|---|
Market Cap | $53.89B | $677.06B |
Sector | Health | Financials |
52-Week High | $239.71 | $362.13 |
52-Week Low | $146.04 | $295.52 |
Enterprise Value | $58.87B | $687.65B |
Dividend Yield | 0.89% | 0.75% |
Volume | — | 10,431,336 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
Visa (V) trades at $357.75, up 2.52% today, with a bullish technical signal and strong fundamentals. Recent quarters show consistent EPS beats, with Q1 2026 actual EPS of $3.31 beating the $3.10 estimate. Revenue grew to $40B in 2025, with a net income margin of 51.68%. Analyst consensus is strongly bullish with 85% buy ratings and a $394.50 price target. The company is advancing in AI-driven commerce with initiatives like Intelligent Commerce Connect, positioning for future growth.
The outlook for Visa remains positive, supported by robust profitability, strategic AI integration, and dominant market position. Key risks include regulatory pressures and competition from fintech and stablecoins. With a consensus price target implying ~10% upside, the stock offers growth potential, but investors should monitor earnings on April 28, 2026, and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →
